Survival of HIV-infected patients with compensated liver cirrhosis
- 13 March 2010
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 24 (5) , 745-753
- https://doi.org/10.1097/qad.0b013e3283366602
Abstract
Since the advent of HAART, liver-related mortality has become the leading cause of non-AIDS deaths in HIV-infected patients in western countries, complications of end-stage liver disease due to chronic hepatitis B, chronic hepatitis C or both being mainly responsible.The incidence and predictors of mortality were examined in HIV-infected patients with compensated liver cirrhosis. The accuracy of three different methods (elastometry, Child-Pugh and Model for End-Stage Liver Disease scores) to predict mortality was further examined. Cirrhosis was defined for hepatic elastometry values above 14.5 kPa.A total of 194 (11.4%) out of 1706 HIV-positive individuals were cirrhotic and were prospectively followed since October 2004 until December 2008. Overall, 89% of cirrhotic individuals had chronic hepatitis C, 10.3% chronic hepatitis B, 4.6% hepatitis delta and 4.1% liver disease of other causes or unknown cause. The overall mortality rate was 5.8 deaths per 100 patient-years. Multivariate analyses showed that age of at least 50 years (hazard ratio 4.76, 95% confidence interval 1.66-13.59, P = 0.004), CD4 cell counts below 200 cells/microl (hazard ratio 3.01, 95% confidence interval 1.26-7.23, P = 0.03) and detectable plasma HIV-RNA (hazard ratio 3.97, 95% CI, 1.53-10.27, P = 0.005) were associated with mortality. A baseline Model for End-stage Liver Disease score of at least 11 (P = 0.03) and hepatic elastometry values above 28.75 kPa (P = 0.001) were independent predictors of mortality.The death rate in HIV-infected patients with compensated liver cirrhosis in the HAART era is 5.8% yearly, higher than mortality previously reported for either HIV-uninfected individuals with cirrhosis or noncirrhotic HIV-positive patients. Factors associated with mortality were older age, low CD4 cell counts and detectable plasma HIV-RNA. Both Model for End-Stage Liver Disease and especially hepatic elastometry accurately predicted mortality in this population.Keywords
This publication has 47 references indexed in Scilit:
- Fast Fibrosis Progression Between Repeated Liver Biopsies in Patients Coinfected with Human Immunodeficiency Virus/Hepatitis C Virus†Hepatology, 2009
- Diagnosis and Epidemiology of CirrhosisMedical Clinics of North America, 2009
- Liver‐related deaths in HIV‐infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 Study in collaboration with the Mortalité 2005 survey, ANRS EN19)*HIV Medicine, 2009
- Liver Complications Have Reached a Plateau as Cause of Hospital Admission and Death in HIV Patients in MadridAIDS Research and Human Retroviruses, 2009
- Impact of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysisWorld Journal of Gastroenterology, 2009
- Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adultsAIDS, 2007
- Liver-Related Deaths in Persons Infected With the Human Immunodeficiency VirusArchives of internal medicine (1960), 2006
- Decline in the AIDS and death rates in the EuroSIDA study: an observational studyThe Lancet, 2003
- Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patientsHepatology, 1999
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998